Abstract
Lung cancer accounts for the second most frequent solid tumor and for about one in four deaths by cancer. Survival of lung cancer has improved since the 1990s because of early tumor detection, therapeutic advances through improvements in surgical techniques, and the development of immunotherapy and targeted therapy.1 However, new treatments resulted in new life-threatening side effects likely to require ICU admission.2,3
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
